Skip to main content
. 2021 Feb 27;22(5):2397. doi: 10.3390/ijms22052397

Figure 4.

Figure 4

Effects of JMV2959 and ghrelin on WIN55,212-2-seeking lever-pressing/relapse-like behavior, observed on the twelfth day of forced abstinence of the WIN55,212-2 intravenous self-administration (IVSA) in active/inactive lever-pressing and percentage of the baseline mean (mean of the last three baselines before pretreatments, 5.-7. bas). Saline (1 mL/kg) or JMV2959 (3 mg/kg) or ghrelin (40 µg/kg) were administered intraperitoneally 20 min before the 120-min session, when the rats were in the IVSA cages not connected with the infusion pump. The IVSA relapse-test data went through logarithmic transformation before the statistical analysis; thus, in the graphs are presented original data together with significances obtained from the transformed ANOVA results. However, the percentage data were analyzed directly/not transformed using the Kruskal–Wallis one-way analysis followed by a Dunn´s test. The means of active lever-pressing in the groups are presented as follows: Saline (open bar) (n = 9), JMV2959 (filled bar) (n = 10), ghrelin (striped bar) (n = 8). Differences between the groups in comparison to the saline group are expressed as ## p < 0.001, ### p < 0.01. Differences between active and inactive lever-pressing are expressed as *** p < 0.001. The results are presented as group means with 95% confidence intervals.